Hydroxychloroquine treatment effective against anogenital lichen sclerosus: Study
A new study published in the recent issue of the International Journal of Dermatology unveiled the positive potential of hydroxychloroquine in treating anogenital lichen sclerosus because of its high response rates and low frequency of side effects. Few studies in the past have examined the effectiveness of hydroxychloroquine in the management of anogenital or extragenital lichen sclerosus. Ignoring this disease might result in more severe scarring and the development of malignant transformation. In order to examine the clinicopathological characteristics, treatment response, outcomes of patients diagnosed with extragenital or anogenital lichen sclerosus, and treatment with hydroxychloroquine therapy, the team led by Christeebella Akpala conducted this comprehensive study.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.